PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Jun-2024 CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S CS MEDICA
10-Jun-2024 MEDICLIN: Annual General Meeting of MEDICLIN AG approves all proposed resolutions MEDICLIN AG
10-Jun-2024 Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity Biophytis
10-Jun-2024 DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024 Defence Therapeutics Inc.
07-Jun-2024 HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate... HighTide Therapeutics, Ltd.
07-Jun-2024 New US headquarters opened by mass photometry pioneers Refeyn Refeyn
07-Jun-2024 16th Edition Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs Conference marcus evans
07-Jun-2024 Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00 Medios AG
07-Jun-2024 Combined General Meeting of June 24, 2024 Biophytis
07-Jun-2024 Cannovum Cannabis AG: Bundestag confirms Cannovum Cannabis AG's business model for cultivation clubs, legal certainty for recreational cannabis producers Cannovum Cannabis AG
06-Jun-2024 Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO MorphoSys AG
06-Jun-2024 PM Society Digital Awards – 12th September 2024 - Tickets Now on Sale! PM Society
06-Jun-2024 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
06-Jun-2024 Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe Medios AG
06-Jun-2024 M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024 M1 Kliniken AG
06-Jun-2024 DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE Defence Therapeutics Inc.
05-Jun-2024 Newron Pharmaceuticals will host its 2024 Investor Day on June 25 in New York City Newron Pharmaceuticals S.p.A.
05-Jun-2024 Otsuka announces new results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in people with hereditary angioedema Otsuka Pharmaceutical Europe Ltd.
04-Jun-2024 QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments QUANTRO Therapeutics GmbH
04-Jun-2024 Cybersecurity Incident at Synnovis in UK SYNLAB AG